Search results

Found 2,503 pages
AUTHOR: Peter Mansell

Results per page

10 20 50 100

Sort by

Relevance Date

25 May 2009:

PPD announces management shake-up

A former brigadier general in the US Army has been appointed chief executive officer (CEO) of PPD, Inc, the US-based contract research organisation (CRO) that, like many other companies in the sector, has been feeling the pinch of recession of late.

by Peter Mansell

https://www.pharmatimes.com/news/ppd_announces_management_shake-up_984835

26 Feb 2013:

WCCT launches special-population recruitment tool

A special-population recruitment-management tool (RMT) for both early- and late-phase clinical trials is being rolled out by US-based contract research organisation (CRO) WCCT Global. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/wcct_launches_special-population_recruitment_tool_1004529

25 Jun 2008:

Chiltern plugs Pinnacle gaps in Western Europe

UK-based contract research organisation (CRO) Chiltern International will provide pharmacovigilance/safety reporting and medical information services in Western Europe to Pinnacle Biologics, a recently formed “full-service pharmaceutical and

by Peter Mansell

https://www.pharmatimes.com/news/chiltern_plugs_pinnacle_gaps_in_western_europe_986754

20 Jul 2009:

PHT, CMIC team up on ePRO solutions

US-based company PHT Corporation is expanding the customer base for its electronic patient-reported outcome (ePRO) solutions through an alliance with Japanese contract research organisation (CRO) CMIC. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/pht,_cmic_team_up_on_epro_solutions_984000

23 Mar 2009:

Quintiles tests risk management pulse with RisQ

US-based contract research organisation (CRO) Quintiles Transnational has developed a new tool to help biopharmaceutical companies assess their relative risk-management preparedness. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/quintiles_tests_risk_management_pulse_with_risq_985224

22 Jul 2009:

Restructuring dilutes ICON’s Q2 earnings

Restructuring charges cut into ICON’s earnings for the second quarter ended 30 June, leaving operating income 16.5% lower at US$20.4 million despite a marginal improvement (+0.8%) in net revenues to US$220.0 million. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/restructuring_dilutes_icons_q2_earnings_983976

18 Aug 2008:

Parexel completes on ClinPhone acquisition

The Perceptive Informatics subsidiary of US-based contract research organisation (CRO) Parexel International is now “one of the industry’s largest eClinical technology providers”, its parent company said on closing its acquisition of ClinPhone

by Peter Mansell

https://www.pharmatimes.com/news/parexel_completes_on_clinphone_acquisition_988054

8 Jul 2010:

Synexus expands clinical trial capacity in Poland

UK-based patient recruitment and trial management business Synexus is expanding its operations in Gydnia, where it acquired a clinical trial centre along with two others in Poland last August. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/synexus_expands_clinical_trial_capacity_in_poland_982957

27 Jul 2009:

Synexus doubles head office capacity

UK-based patient recruitment and clinical trial management business Synexus has doubled capacity at its head office in Chorley, Manchester to accommodate continued strong growth in its home country as well as Central and Eastern Europe, India and

by Peter Mansell

https://www.pharmatimes.com/news/synexus_doubles_head_office_capacity_983956

20 Apr 2009:

SCRM teams up with Chinese stem cell research centre

The Scottish Centre for Regenerative Medicine (SCRM) has signed a collaborative agreement for stem cell research with China’s Peking University Stem Cell Research Centre. - News - PharmaTimes

by Peter Mansell

https://www.pharmatimes.com/news/scrm_teams_up_with_chinese_stem_cell_research_centre_985052